Literature DB >> 31090673

Firefighting Induces Acute Inflammatory Responses that are not Relieved by Aspirin in Older Firefighters.

Denise L Smith1, Nicholas M G Friedman, Samuel I Bloom, William L Armero, Brandt D Pence, Marc D Cook, Bo Fernhall, Gavin P Horn, Jeff Woods.   

Abstract

OBJECTIVE: Sudden cardiac events account for 40% to 50% of firefighter line-of-duty deaths. Inflammatory proteins are strong biomarkers of cardiovascular inflammation. The present study investigated the effects of aspirin supplementation on inflammatory biomarkers following firefighting.
METHODS: Using a randomized, placebo-controlled, double-blind crossover design, 24 male firefighters (48.2 ± 5.9 years) were allocated into four conditions: acute (81 mg; single-dose) aspirin and placebo supplementation, and chronic (81 mg; 14 days) aspirin and placebo supplementation. Inflammatory proteins [interleukin (IL)-6, C-reactive protein (CRP), intracellular adhesion molecule (ICAM)-1, P-selectin, matrix metalloproteinase-9 (MMP-9)] and antioxidant potential [total antioxidant capacity (TAC)] were measured pre- and post-structural firefighting drills.
RESULTS: Firefighting activities significantly increased IL-6, MMP-9, and P-Selectin; however, no changes in TAC and ICAM-1 were detected. Neither acute nor chronic aspirin supplementation attenuated this inflammatory response.
CONCLUSION: Firefighting significantly increases inflammatory biomarkers and neither acute nor chronic low-dose aspirin mitigates this response.

Entities:  

Year:  2019        PMID: 31090673     DOI: 10.1097/JOM.0000000000001626

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  1 in total

1.  Are Inflammatory Markers an Indicator of Exposure or Effect in Firefighters Fighting a Devastating Wildfire? Follow-up of a Cohort in Alberta, Canada.

Authors:  Nicola Cherry; Jeremy Beach; Jean-Michel Galarneau
Journal:  Ann Work Expo Health       Date:  2021-07-03       Impact factor: 2.179

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.